The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Rhabdomyosarcoma in adults: A retrospective analysis of 171 patients treated at a single institution
Abstract
BACKGROUND: The goal of the current study was to clarify treatment outcomes for adult patients with rhabdomyosarcoma (RMS). Published series have reported definitively worse results for adults with RMS compared with children with RMS. This finding casts doubt on whether RMS is the same disease in adults as it is in children. METHODS: Of 190 patients with RMS who were age 18 years or older and whose cases were recorded over a 25‐year span in the pathology database of the Istituto Nazionale Tumori (Milan, Italy), 171 could be analyzed retrospectively for treatment outcome. The authors attempted to stratify patients according to the degree to which they had been treated appropriately, based on current treatment guidelines for childhood RMS. RESULTS: The overall rate of response to chemotherapy was 85%. For the entire series, 5‐year event‐free survival and 5‐year overall survival (OS) were 28% and 40%, respectively. Among the 110 patients with embryonal, alveolar, or ‘not otherwise specified’ RMS, 5‐year OS was 46%; however, 5‐year OS was 61% for patients within this group (39% of the total) who had high scores for appropriate treatment. CONCLUSIONS: The current series parallels other published series in that it confirms the finding of a relatively poor long‐term outcome for adult patients with RMS. However, for patients whose treatment adhered to the current guidelines for treatment of children, outcome was similar to what has been reported in pediatric series. In addition, the rate of response to chemotherapy for the entire series was similar to the rate typically observed among children. These findings suggest that adults and children with RMS should receive similar treatment. Treatment protocols adopted from pediatric programs but tailored to adults could increase adults' chances of receiving appropriate treatment; prospective studies are needed to test this idea. Cancer 2003;98:571–80. © 2003 American Cancer Society. DOI 10.1002/cncr.11550
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Practical Nonparametric Statistics
Groggel, D. J. (2000) · Technometrics · doi:10.1080/00401706.2000.10486067 · Cited by 11,041
Enzinger and Weiss's Soft Tissue Tumors
Weiss, S. W., & Goldblum, J. R. (2001) · Cited by 2,510
Practical Nonparametric Statistics.
Haigh, J., & Conover, W. J. (1981) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2981807 · Cited by 1,503
Intergroup Rhabdomyosarcoma Study-IV: Results for Patients With Nonmetastatic Disease
Crist, W. M., Anderson, J. R., Meza, J. L., Fryer, C., Raney, R. B., Ruymann, F. B., Breneman, J., Qualman, S. J., Wiener, E., Wharam, M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.12.3091 · Cited by 1,087
Principles and Practice of Pediatric Oncology
Labotka, R. J. (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.7.894-a · Cited by 1,046
Frustaci, S., Gherlinzoni, F., De Paoli, A., Bonetti, M., Azzarelli, A., Comandone, A., Olmi, P., Buonadonna, A., Pignatti, G., Barbieri, E., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1238 · Cited by 712
Self-citationRaney, R. B., Anderson, J. R., Barr, F. G., Donaldson, S. S., Pappo, A. S., Qualman, S. J., Wiener, E. S., Maurer, H. M., & Crist, W. M. (2001) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200105000-00008 · Cited by 376
Teaching Social Skills to People with Autism
Weiss, M. J., & Harris, S. L. (2001) · Behavior Modification · doi:10.1177/0145445501255007 · Cited by 297
Crist, W. M., Garnsey, L., Beltangady, M. S., Gehan, E., Ruymann, F., Webber, B., Hays, D. M., Wharam, M., & Maurer, H. M. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.3.443 · Cited by 286
Response to Chemotherapy and Predictors of Survival in Adult Rhabdomyosarcoma
Esnaola, N. F., Rubin, B. P., Baldini, E. H., Vasudevan, N., Demetri, G. D., Fletcher, C. D. �., & Singer, S. (2001) · Annals of Surgery · doi:10.1097/00000658-200108000-00012 · Cited by 169
Staging of Musculoskeletal Neoplasms
Enneking, W. F. (1984) · Springer eBooks · doi:10.1007/978-3-642-69210-9_1 · Cited by 80
[TNM classification--pediatric tumors].
Hayashi, Y., Ohi, R., Okabe, I., Todo, S., Iwafuchi, M., Tsuchida, Y., Takahashi, H., Ohnuma, N., Hashizume, K., Miyano, T., et al. (1998) · PubMed · Cited by 61
(1988) · doi:10.1002/1097-0142(19880115)61:2<209::aid-cncr2820610202>3.0.co;2-l
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Skapek, S. X., Ferrari, A., Gupta, A. A., Lupo, P. J., Butler, E., Shipley, J., Barr, F. G., & Hawkins, D. S. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0051-2 · Cited by 875
Self-citationThe distinctive biology of cancer in adolescents and young adults
on behalf of the Biology and Clinical Trials Subgroups of the US National Cancer Institute Progress Review Group in Adolescent and Young Adult Oncology, Bleyer, A., Barr, R., Hayes-Lattin, B., Thomas, D., Ellis, C., & Anderson, B. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2349 · Cited by 660
Bleyer, A., Budd, T., & Montello, M. (2006) · Cancer · doi:10.1002/cncr.22102 · Cited by 387
Ferrari, A., Sultan, I., Huang, T. T., Rodriguez‐Galindo, C., Shehadeh, A., Meazza, C., Ness, K. K., Casanova, M., & Spunt, S. L. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23252 · Cited by 376
Self-citation
Metadata
- Authors
- Ferrari, A., Dileo, P., Casanova, M., Bertulli, R., Meazza, C., Gandola, L., Navarria, P., Collini, P., Gronchi, A., Olmi, P., Fossati‐Bellani, F., & Casali, P. G.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2003-06-16
- Volume
- 98
- Issue
- 3
- Pages
- 571-580
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1965129745
- Cited by
- 403
- References
- 15
- FWCI
- 3.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.